Arsanis is a leader in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections.

Arsanis, Inc.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ASNS” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.arsanis.com
Disease Focus
STOCK CODENASDAQ: ASNS
Address890 Winter Street, Suite 230, MA 02451-1472WalthamUnited States
890 Winter Street, Suite 230, MA 02451-1472
Waltham
United States
Contact Number+1 781-819-5704
+1 781-819-5704
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arsanis” connections=”true” suffix=””]